BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 27434095)

  • 1.
    Lin G; Lai CH; Tsai SY; Lin YC; Huang YT; Wu RC; Yang LY; Lu HY; Chao A; Wang CC; Ng KK; Ng SH; Chou HH; Yen TC; Hung JH
    J Magn Reson Imaging; 2017 Mar; 45(3):899-907. PubMed ID: 27434095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
    Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
    Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing and validating a multivariable prediction model to improve the diagnostic accuracy in determination of cervical versus endometrial origin of uterine adenocarcinomas: A prospective MR study combining diffusion-weighted imaging and spectroscopy.
    Lin G; Lin YC; Wu RC; Yang LY; Lu HY; Tsai SY; Huang YT; Huang YL; Lu KY; Ng KK; Yen TC; Chao A; Lai CH; Hong JH
    J Magn Reson Imaging; 2018 Jun; 47(6):1654-1666. PubMed ID: 29178414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.
    Wang CC; Lai CH; Huang YT; Chao A; Chou HH; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e499-506. PubMed ID: 22889667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effect of human papillomavirus genotypes in patients with cervical cancer undergoing primary radiotherapy.
    Wang CC; Lai CH; Huang HJ; Chao A; Chang CJ; Chang TC; Chou HH; Hong JH
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1111-20. PubMed ID: 20231068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.
    Senapati R; Nayak B; Kar SK; Dwibedi B
    PLoS One; 2017; 12(11):e0187844. PubMed ID: 29161285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or high-grade precancerous lesions in Chengdu, western China.
    Li J; Zhang D; Zhang Y; Wang X; Lin Y; Hu L
    Int J Gynaecol Obstet; 2011 Feb; 112(2):131-4. PubMed ID: 21092957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
    Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
    Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of human papillomavirus genotype in cervical adeno-adenosquamous carcinoma.
    Lai CH; Chou HH; Chang CJ; Wang CC; Hsueh S; Huang YT; Chen YR; Chang HP; Chang SC; Lin CT; Chao A; Qiu JT; Huang KG; Chen TC; Jao MS; Chen MY; Liou JD; Huang CC; Chang TC; Patsner B
    Eur J Cancer; 2013 Feb; 49(3):633-41. PubMed ID: 23031554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of human papillomavirus genotypes of invasive cervical carcinoma: an analytical cross-sectional study in lower north-east Thailand.
    Wongsena M; Suebsamran P; Panomket P; Tirat S; Wongsena P; Wanram S
    J Med Assoc Thai; 2014 Apr; 97 Suppl 4():S12-9. PubMed ID: 24851559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
    Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran.
    Ghaffari SR; Sabokbar T; Mollahajian H; Dastan J; Ramezanzadeh F; Ensani F; Yarandi F; Mousavi-Jarrahi A; Mohagheghi MA; Moradi A
    Asian Pac J Cancer Prev; 2006; 7(4):529-32. PubMed ID: 17250423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of multiple human papillomavirus infection in Japanese patients with invasive uterine cervical cancer.
    Watari H; Michimata R; Yasuda M; Ishizu A; Tomaru U; Xiong Y; Hassan MK; Sakuragi N
    Pathobiology; 2011; 78(4):220-6. PubMed ID: 21778789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus genotype as a prognostic factor in carcinoma of the uterine cervix.
    Tong SY; Lee YS; Park JS; Namkoong SE
    Int J Gynecol Cancer; 2007; 17(6):1307-13. PubMed ID: 17425678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting and Early Monitoring Treatment Efficiency of Cervical Cancer Under Concurrent Chemoradiotherapy by Intravoxel Incoherent Motion Magnetic Resonance Imaging.
    Zhu L; Zhu L; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X
    J Comput Assist Tomogr; 2017; 41(3):422-429. PubMed ID: 27824669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
    Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
    J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High performance of combined HPV testing and genotyping for HPV16/18/52/58 in triaging women with minor cervical cytological abnormalities in northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Intaraphet S; Siriaunkgul S
    J Med Virol; 2016 Jan; 88(1):135-43. PubMed ID: 26129775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
    Park S; Eom K; Kim J; Bang H; Wang HY; Ahn S; Kim G; Jang H; Kim S; Lee D; Park KH; Lee H
    BMC Cancer; 2017 Sep; 17(1):658. PubMed ID: 28934937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
    Liu Y; Lu Z; Xu R; Ke Y
    Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of R2* obtained from T2*-weighted imaging in predicting the prognosis of advanced cervical squamous carcinoma treated with concurrent chemoradiotherapy.
    Li XS; Fan HX; Fang H; Song YL; Zhou CW
    J Magn Reson Imaging; 2015 Sep; 42(3):681-8. PubMed ID: 25581675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.